Posting reference material for the Covid19 PCR and RDT tess developed by Access Bio (for which AT1 Galileo devices will be used)
Bl**mberg interview: https://www.bloomberg.com/news/videos/2020-08-12/intrivo-diagnostics-gets-fda-approval-for-covid-tests-video
Interview is with Reeve Benaron, chairman of Intrivio Diagnostics, distributer for Access Bio's PCR and RDT tests in North America
These tests are branded: CareStart COVID-19 IgM/IgG (Rapid Diagnostic Test for Detection of SARS-CoV-2 IgM/IgG Ab)...this is NOT the product using AT1 device yet...but its highly relevant.
Reeve talks about:
- the accuracy of these antibody tests (both PCR and lateral flow developed by Access Bio)
- distribution/usage potential at CVS, Walgreens, Walmart etc and also for future at-home test opportunities
- future tests to differentiate influenza vs Covid19 (similar symptoms, common mis-diagnosis today)
The 'test strip' that is going to be in the Access Bio + AT1 device is this same technology. if anyone is interested in the 'instructions for usage', for how the device works: https://intrivo.com/wp-content/uploads/2020/07/5-EUA201309-Access-Bio-IFU-Serology-07-24-2020.pdf
This is relevant to AT1 because the current CareStart rapid test version does not have AT1 developed all-in-one integrated functions, which makes it riskier and more cumbersome for sample and testing steps. It uses '...a separate lancet to generate a blood sample and a separate manual pipette to collect and deliver blood to the test strip'.
Here is an article referenced via AT1 website news links which also puts all this together: https://www.biospace.com/article/releases/atomo-diagnostics-and-access-bio-partner-to-expand-access-to-covid-19-blood-based-rapid-testing-in-north-america/
Remains to be seen if these CareStart tests (the rapid test version) will utilise AT1 devices only in future (with Atomo name on labelling) or it will be a completely different product in the range (maybe with slightly higher price differentiating the with/without integrated function?)..
- Forums
- ASX - By Stock
- Ann: Atomo & Access Bio enter North American COVID-19 partnership
Posting reference material for the Covid19 PCR and RDT tess...
-
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $17.25M |
Open | High | Low | Value | Volume |
2.5¢ | 2.7¢ | 2.5¢ | $17.71K | 676.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 101596 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.026 |
2 | 319327 | 0.025 |
3 | 700383 | 0.024 |
4 | 1016000 | 0.023 |
7 | 1164373 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 101596 | 1 |
0.028 | 206666 | 2 |
0.029 | 452248 | 7 |
0.030 | 632393 | 9 |
0.031 | 159930 | 3 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |